Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic

Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic

The COVID-19 pandemic has caused major disruptions in ambulatory care. In this interview with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical School discusses how access to care and preventive services changed for different racial and ethnic groups in the US from 2019 to 2022.

Related Content:

Episoder(227)

COVID-19 CDC Update – Early January 2022

COVID-19 CDC Update – Early January 2022

Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boos...

11 Jan 202232min

COVID-19 Update: Omicron Variant

COVID-19 Update: Omicron Variant

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a ...

6 Des 202138min

Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Results With Persistent Physical Symptoms

Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Results With Persistent Physical Symptoms

Interview with Cédric Lemogne, MD, PhD, and Joane Matta, PhD, authors of Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among Fr...

8 Nov 202127min

October 2021 Medical News Summary

October 2021 Medical News Summary

COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes; Moving COVID-19 Testing Out of the Clinic and Into the Home; The Lingua Franca of Addiction—Stigmatizing Words That Wound Related Content: ...

26 Okt 202120min

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Pa...

7 Okt 202117min

A New Vision for Nursing Homes

A New Vision for Nursing Homes

The longstanding shortcomings of the US nursing home model became more visible during the COVID-19 crisis. Terry Fulmer, PhD, RN, a geriatric nurse practitioner and president of the John A. Hartford F...

6 Okt 202124min

COVID-19 in Canada—Experience and Response to Waves 2 and 3

COVID-19 in Canada—Experience and Response to Waves 2 and 3

Canadian law gives the country's individual provinces and territories primary responsibility for coronavirus containment and mitigation. JAMA Associate Editor Preeti Malani, MD, MSJ, from the Universi...

28 Sep 202123min

Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic

Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic

Interview with Grayson W. Armstrong, MD, MPH, author of Association of Patient Characteristics With Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic, and Fasika Ambachew Woreta, MD, MP...

23 Sep 202116min

Populært innen Vitenskap

fastlegen
rekommandert
tingenes-tilstand
jss
rss-rekommandert
sinnsyn
liberal-halvtime
forskningno
tomprat-med-gunnar-tjomlid
villmarksliv
rss-nysgjerrige-norge
fjellsportpodden
kvinnehelsepodden
dekodet-2
smart-forklart
rss-paradigmepodden
nordnorsk-historie
vett-og-vitenskap-med-gaute-einevoll
nevropodden
rss-overskuddsliv